Biotech

All Articles

BioAge eyes $180M from IPO, exclusive positioning for being overweight tests

.BioAge Labs is considering around $180 million in initial proceeds from an IPO and an exclusive pla...

Merck's LAG-3 combination falls short colorectal cancer cells stage 3 research

.A try through Merck &amp Co. to open the microsatellite stable (MSS) metastatic colon cancer cells ...

Spanish VC closes $200M life scientific researches fund

.Spain-based Asabys Allies has finalized a fund of 180 thousand europeans ($ 200 million), cash that...

BioAge produces $198M coming from IPO as weight problems biotech signs up with Nasdaq

.BioAge Labs is actually bringing in just about $200 thousand through its Nasdaq IPO this morning, w...

Acadia brings BMS veterinarian aboard as CEO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant leadership hirings, firings an...

Cassava spends $40M over presumably confusing Alzheimer's improve

.Cassava Sciences has accepted to pay $40 thousand to resolve an examination into cases it made dece...

Merck bags choices on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has actually picked up alternatives on two Evaxion Biotech injection prospects, payi...

Enanta's RSV antiviral crushes viral load in challenge research

.Enanta Pharmaceuticals has actually linked its own respiratory system syncytial virus (RSV) antivir...

Biogen canisters SAGE-324 partnership after important tremor stop working

.Biogen has provided the final ceremonies to its collaboration with Sage Therapeutics on SAGE-324, j...

AbbVie Parkinson's medication coming from $8.7 B Cerevel purchase ratings

.On the exact same time that some Parkinson's ailment medications are actually being disputed, AbbVi...